World Journal of Clinical Cases - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

147

WORD

HTML

1310

Tables (1-3)

349

Sum=1869

Publishing Process of This Article

Item

Count

Browse

175

Download

529

Sum=704

Jan 16, 2024 (publication date) through Apr 28, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Sun SS, Guo XD, Li WD, Chen JL. Lenvatinib combined with sintilimab plus transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma. World J Clin Cases 2024; 12(2): 285-292 [PMID: 38313649 DOI: 10.12998/wjcc.v12.i2.285]
URL:	https://www.wjgnet.com/2307-8960/full/v12/i2/285.htm

Number	Citing Articles
1	Feng Han, Xiao-Han Wang, Chen-Zhou Xu. Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2024; 16(7): 3308-3320 doi: 10.4251/wjgo.v16.i7.3308 Abstract(328) \| Core Tip(366) \| Full Article(HTML)(982) \| Full Article with Cover (PDF)-6375K(62) \| Audio-5586K(12) \| Peer-Review Report-218K(45) \| Answering Reviewers-89K(36) \| Full Article (PDF)-6087K(74) \| Full Article (XML)-162K(49) \| Times Cited (0) \| Total Visits (3046) \| Open
2	Fei-Yu Zhao, Xiao-Ming Zhang, Nian-Song Qian. Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy. World Journal of Gastroenterology 2025; 31(10): 104429 doi: 10.3748/wjg.v31.i10.104429 Abstract(187) \| Core Tip(169) \| Full Article(HTML)(506) \| Full Article with Cover (PDF)-621K(75) \| Audio-1658K(13) \| Peer-Review Report-175K(20) \| Answering Reviewers-38K(26) \| Full Article (PDF)-366K(50) \| Full Article (XML)-45K(25) \| Times Cited (0) \| Total Visits (1550) \| Open